Growth Metrics

Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2026)

Quarterly results put Interest & Investment Income at $2.1 million for Q1 2026, down 10.26% from a year ago — trailing twelve months through Mar 2026 was $9.7 million (up 6.03% YoY), and the annual figure for FY2025 was $9.9 million, up 4.59%.

Solid Biosciences has reported Interest & Investment Income over the past 10 years, most recently at $2.1 million for Q1 2026.

  • Interest & Investment Income reached $2.1 million in Q1 2026 per SLDB's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.0 million in Q2 2025 and bottomed at $54000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 5 years was $2.1 million (2025), compared with a mean of $1.9 million.
  • The largest annual shift saw Interest & Investment Income skyrocketed 3231.48% in 2023 before it dropped 13.24% in 2025.
  • Over 5 years, Interest & Investment Income stood at $1.5 million in 2022, then grew by 14.73% to $1.8 million in 2023, then rose by 9.38% to $1.9 million in 2024, then rose by 6.6% to $2.1 million in 2025, then increased by 0.58% to $2.1 million in 2026.
  • Business Quant data shows Interest & Investment Income for SLDB at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 7.90 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 114.80 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - 305,000.00
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 26.60 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 2.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.06 Mn
Dec 31, 2025 2.05 Mn
Sep 30, 2025 2.59 Mn
Jun 30, 2025 2.97 Mn
Mar 31, 2025 2.30 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 2.33 Mn
Jun 30, 2024 2.57 Mn
Mar 31, 2024 2.65 Mn
Dec 31, 2023 1.76 Mn
Sep 30, 2023 1.96 Mn
Jun 30, 2023 2.06 Mn
Mar 31, 2023 1.80 Mn
Dec 31, 2022 1.53 Mn
Sep 30, 2022 735,000.00
Jun 30, 2022 293,000.00
Mar 31, 2022 54,000.00
Jun 30, 2021 -13,000.00
Mar 31, 2021 -14,000.00
Dec 31, 2020 -16,000.00
Sep 30, 2020 -20,000.00
Jun 30, 2020 -13,000.00
Mar 31, 2020 164,000.00
Dec 31, 2019 299,000.00
Sep 30, 2019 406,000.00
Jun 30, 2019 367,000.00
Mar 31, 2019 508,000.00
Dec 31, 2018 382,000.00
Sep 30, 2018 92,000.00
Jun 30, 2018 80,000.00
Mar 31, 2018 65,000.00
Dec 31, 2017 54,000.00
Sep 30, 2017 51,000.00
Jun 30, 2017 52,000.00
Mar 31, 2017 62,000.00